0000950170-23-023627.txt : 20230523 0000950170-23-023627.hdr.sgml : 20230523 20230523160620 ACCESSION NUMBER: 0000950170-23-023627 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230519 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230523 DATE AS OF CHANGE: 20230523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 23948967 BUSINESS ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 8-K 1 vir-20230519.htm 8-K 8-K
0001706431false00017064312023-05-192023-05-19

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 19, 2023

Vir Biotechnology, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

Delaware

001-39083

81-2730369

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

499 Illinois Street, Suite 500

San Francisco, California 94158

(Address of principal executive offices) (Zip Code)

(415) 906-4324

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.0001 par value

VIR

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

On May 19, 2023, Vir Biotechnology, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). As of March 30, 2023, the record date for the Annual Meeting, 133,930,936 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below.

Proposal 1. Election of Directors

The Company’s stockholders elected the four persons listed below as Class I Directors, each to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows:

 

 

 

 

 

 

 

Votes For

Votes Withheld

Broker Non-Votes

Robert More

109,608,096

897,767

8,334,036

Janet Napolitano

98,720,333

11,785,530

8,334,036

Vicki Sato, Ph.D.

98,355,146

12,150,717

8,334,036

Elliott Sigal, M.D., Ph.D.

 

109,721,001

 

784,862

 

8,334,036

Proposal 2. Advisory Vote on Executive Compensation

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The final voting results are as follows:

 

 

 

 

 

 

 

Votes For

Votes Against

Abstentions

Broker Non-Votes

106,031,723

4,377,092

97,048

8,334,036

Proposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The final voting results are as follows:

 

 

 

 

 

 

 

Votes For

Votes Against

Abstentions

Broker Non-Votes

118,688,387

41,676

109,836

0

 

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

Vir Biotechnology, Inc.

 

 

 

 

Dated: May 23, 2023

 

By:

/s/ Sung Lee

 

 

 

Sung Lee

 

 

 

Executive Vice President, Chief Financial Officer and Secretary

 

 

 

 EX-101.PRE 2 vir-20230519_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 3 vir-20230519_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, City or Town Soliciting Material Amendment Flag Entity Incorporation, State or Country Code City Area Code Document Period End Date Entity Address, Postal Zip Code Securities Act File Number Entity Address, Address Line One Entity Tax Identification Number Entity Emerging Growth Company Entity Registrant Name Pre-commencement Tender Offer Title of 12(b) Security Entity Address, State or Province Document Type Written Communications Security Exchange Name Entity Central Index Key Local Phone Number Pre-commencement Issuer Tender Offer Cover [Abstract] Trading Symbol EX-101.SCH 4 vir-20230519.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
May 19, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 19, 2023
Entity Registrant Name Vir Biotechnology, Inc.
Entity Central Index Key 0001706431
Entity Emerging Growth Company false
Securities Act File Number 001-39083
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 81-2730369
Entity Address, Address Line One 499 Illinois Street, Suite 500
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94158
City Area Code (415)
Local Phone Number 906-4324
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol VIR
Security Exchange Name NASDAQ
XML 6 vir-20230519_htm.xml IDEA: XBRL DOCUMENT 0001706431 2023-05-19 2023-05-19 0001706431 false 8-K 2023-05-19 Vir Biotechnology, Inc. DE 001-39083 81-2730369 499 Illinois Street, Suite 500 San Francisco CA 94158 (415) 906-4324 false false false false Common Stock, $0.0001 par value VIR NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports vir-20230519.htm vir-20230519.xsd vir-20230519_lab.xml vir-20230519_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "vir-20230519.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "vir-20230519.htm" ] }, "labelLink": { "local": [ "vir-20230519_lab.xml" ] }, "presentationLink": { "local": [ "vir-20230519_pre.xml" ] }, "schema": { "local": [ "vir-20230519.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "vir", "nsuri": "http://www.vir.bio/20230519", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "vir-20230519.htm", "contextRef": "C_c7f0d746-178e-47b8-844f-971f13b148f8", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "vir-20230519.htm", "contextRef": "C_c7f0d746-178e-47b8-844f-971f13b148f8", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vir.bio/20230519/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-023627-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-023627-xbrl.zip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end